Business Description
Abivax SA
ISIN : FR0012333284
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.71 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | -0.42 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -5.3 | |||||
3-Year EPS without NRI Growth Rate | -6.5 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | 35.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.84 | |||||
9-Day RSI | 39.74 | |||||
14-Day RSI | 40.14 | |||||
6-1 Month Momentum % | 61.14 | |||||
12-1 Month Momentum % | -18.72 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.08 | |||||
Quick Ratio | 4.08 | |||||
Cash Ratio | 3.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -63.8 | |||||
Shareholder Yield % | -46.03 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -156.24 | |||||
ROA % | -77.26 | |||||
ROIC % | -229.33 | |||||
ROC (Joel Greenblatt) % | -15040.88 | |||||
ROCE % | -94.46 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.04 | |||||
Price-to-Tangible-Book | 4.63 | |||||
EV-to-EBIT | -4.38 | |||||
EV-to-Forward-EBIT | -4.36 | |||||
EV-to-EBITDA | -4.4 | |||||
EV-to-Forward-EBITDA | -4.42 | |||||
EV-to-Forward-Revenue | 478.82 | |||||
EV-to-FCF | -5.8 | |||||
Price-to-Net-Current-Asset-Value | 5.11 | |||||
Price-to-Net-Cash | 6.08 | |||||
Earnings Yield (Greenblatt) % | -22.83 | |||||
FCF Yield % | -12.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Abivax SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -3.271 | ||
Beta | 1.4 | ||
Volatility % | 58.86 | ||
14-Day RSI | 40.14 | ||
14-Day ATR (€) | 0.436987 | ||
20-Day SMA (€) | 13.047 | ||
12-1 Month Momentum % | -18.72 | ||
52-Week Range (€) | 7.89 - 19.18 | ||
Shares Outstanding (Mil) | 62.92 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abivax SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abivax SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Abivax SA Frequently Asked Questions
What is Abivax SA(XPAR:ABVX)'s stock price today?
When is next earnings date of Abivax SA(XPAR:ABVX)?
Does Abivax SA(XPAR:ABVX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |